Article
In vitro and in vivo disease models of cardiac amyloidosis: progress, pitfalls, and potential.
Cardiovascular research - 28 Oct 2025
Qin Jiabin, Qiu Zeping, Fan Yingze, Xiong Qipeng, Lei Zhiyong, Wei Jin, van der Harst Pim, Minnema Monique C, Sluijter Joost P G, van Mil Alain, Oerlemans Marish I F J
Abstract excerpt
Amyloid light chain (AL) and transthyretin amyloidosis (ATTR)-induced cardiomyopathy are life-threatening protein misfolding disorders characterized by amyloid fibril deposition in the heart, which significantly impairs cardiac function. The lack of representative disease models has impeded progress in understanding the underlying mechanisms and hindered the discovery and development of specific biomarkers and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
